Cargando…
Current status and trend of clinical development of orphan drugs in China
BACKGROUND: Rare diseases have been increasingly recognized as unmet medical and health needs worldwide; a growing demand for the development of orphan drugs emerges subsequently. Therefore, it is of great interest for both the Chinese regulatory agency and pharmaceutical companies to keep tract on...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327367/ https://www.ncbi.nlm.nih.gov/pubmed/35897012 http://dx.doi.org/10.1186/s13023-022-02440-4 |